Research ArticleHIV

Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection

See allHide authors and affiliations

Science Translational Medicine  15 Feb 2017:
Vol. 9, Issue 377, eaag1809
DOI: 10.1126/scitranslmed.aag1809

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Peak HIV viremia pushes CD8+ T cells

Aside from CD4+ T cell death, the immune system in chronically infected HIV patients is dysfunctional, including the inability of CD8+ T cells to control the virus. Animal studies with simian immunodeficiency virus have suggested that early CD8+ T cell responses may be capable of reducing viral burden, but getting access to patient samples at the earliest stage of infection is challenging. Takata et al. examined a large cohort of acutely infected patients that were given antiretroviral therapy (ART) upon enrollment in the study to evaluate T cell activation and HIV viral load over time, allowing them to parse out immune function (or dysfunction) based on acute stages of infection. They saw that CD8+ T cell responses were a little slow to ramp up but that activated CD8+ T cells present after initiation of ART could reduce the magnitude of the viral reservoir. These findings confirm that targeting CD8+ T cells at the early stage of infection could lead to viral eradication.